INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / IBD BREAKOUT
Total 13F shares
59,770
Share change
+2,339
Total reported value
$2,313,422
Price per share
$38.71
Number of holders
12
Value change
+$104,048
Number of buys
4
Number of sells
6

Institutional Holders of INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) as of Q4 2021

As of 31 Dec 2021, INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,770 shares. The largest 10 holders included SUSQUEHANNA INTERNATIONAL GROUP, LLP, Wealthcare Advisory Partners LLC, CITADEL ADVISORS LLC, ADVISOR GROUP HOLDINGS, INC., Cambridge Investment Research Advisors, Inc., American Portfolios Advisors, Patriot Financial Group Insurance Agency, LLC, MORGAN STANLEY, Asset Dedication, LLC, and Ahrens Investment Partners LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.